ANN ARBOR, Mich., – Nov 26, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”) (“Kraig Labs”), the leading developer of spider silk based fibers, announced today the following letter to our shareholders from Kim Thompson, the Company’s Chairman, CEO, and founder.
Biocraft Laboratories shareholders,
has always been to develop and produce the best spider silk based fibers. Our suite of technological innovations has
positioned Kraig Biocraft Laboratories to remain firmly in the leadership role.
2019 brought us the beginning of production operations, perhaps the most
significant milestone in the Company’s work to commercialize spider silk since
the creation of the first transgenics.
Kraig Biocraft Laboratories officially transitioned into the increased
production and scalability phase of our operations. This operational focus will serve as the foundation
in creating and maintaining long-term shareholder value. We are preparing to
expand our footprint and deliver our largest ever commercial production of spider
coming months the Company will be delivering the first shipment of finished
silk from the factory in Vietnam.
Simultaneously we are continuing to expand our production capacity. With these developments, we are now preparing
to fulfill material deliveries to numerous end markets that we are targeting
for growth in 2020.
focus on the advancement of commercialization activities, we have determined
that this is the time to elevate the Company from the OTC Markets Venture
Exchange to a national exchange. Our
efforts to uplist to a national exchange are well underway, with several key
pieces of this process complete. We have
elected four new board members, who stand ready to take their positions to
fulfill governance requirements of the national exchanges. We held our annual shareholder meeting and
gained shareholder approval for our move to uplist.
expansion capital and listing on a national exchange will immediately impact
the Company. This capital will address national exchange listing requirements
and serve to underpin the Company’s work to rapidly expand capacity, build the
inventory to grow our business, bring new products to market, and establish
sales channel partnerships. This growth will benefit all of our shareholders.
During the past 12 months our research team has been working quietly to deliver breakthroughs in technologies and new products in the lab. Accelerating our development time cycle with the addition of new personnel and processes has delivered technologies and transgenics which I believe will take us far beyond Dragon Silk. This year the Company continued to expand its intellectual property portfolio by filing the first five of many expected provisional patent applications. We are also vigorously prosecuting the patent applications previously filed in conjunction with the University of Notre Dame.
shown tremendous growth in 2019 by hitting nearly every mark in our business
plan. That growth includes; obtaining
approvals to commence rearing operations in Vietnam, completing the buildout of
our factory in Vietnam, the initial scale up of our overseas production
operations, advancements in our R&D and IP portfolio, strengthening our
corporate governance in preparations for bigger things, and growth of our market
cap by more than 285%.
developments over the last year have given us lots of reasons to be thankful.
is now preparing to take a giant leap that will enhance our global
presence. Our management has been
working hard over the last quarter to prepare for that leap and we believe
those efforts will lead to even greater successes in 2020. We intend to use our new position as a launching
While I am
thrilled over our progress and growth in 2019, this is only the foundation upon
which we intend to build. Our new
assignment is to deliver spider silk to end customers and bring everything to
fruition in 2020.
enter the holiday season I would like to express my personal appreciation to
our shareholders. We are thinking of
their long term interests with every corporate decision we make. I would also like to thank our exceptional
teams at Kraig Labs and Prodigy Textiles.
I have great appreciation for the Kraig Labs family, including our
all for your support, and I wish you and your loved ones a Happy Thanksgiving
and a blessed holiday.
CEO, Chairman, and
founder of Kraig Biocraft Laboratories, Inc.
To view the most recent news from
Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories,
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com),
a reporting biotechnology company, is the leading developer of genetically
engineered spider silk based fiber technologies.
The Company has achieved a series of
scientific breakthroughs in the area of spider silk technology with
implications for the global textile industry.
Cautionary Statement Regarding
Forward Looking Information
Statements in this press release
about the Company’s future and expectations other than historical facts are
“forward-looking statements.” These statements are made on the basis of
management’s current views and assumptions. As a result, there can be no
assurance that management’s expectations will necessarily come to pass. These
forward-looking statements generally can be identified by phrases such as
“believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,”
“hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,”
“could” or other words or phrases of similar import. Forward looking statements
include descriptions of the Company’s business strategy, outlook, objectives,
plans, intentions and goals. All such forward-looking statements are subject to
certain risks and uncertainties that could cause actual results to differ
materially from those in forward-looking statements. This press release does
not constitute an offer to sell or the solicitation of an offer to buy any
Ben Hansel, Hansel